Quora is probably the best social network-ish website ever. It probably gathers all the smartest people on the internet. After I started using Quora I quit fb and twitter. It's not an apples to apples comparison but you get the idea. There are much less trolls because most people on Quora are smart enough to do other things.
Due to a string of bad decisions, including but not limited to the Starbucks deal and the Square Wallet, Square's undervalued. If they can sit up and grow their processing volume, their share price will appreciate greatly and go much higher than $9. They also need to find a way to minimize their losses on low amount payments, since they make losses on some of them. Their small business loans seem like an interesting and propitious part of their overall business going forward.
Golang and I have had a mainly wonderful relationship. I think that the performance and concurrency features that it brings to the table are unparalleled. No that Golang is just 6 years old and probably has a few more decades of relevance. Although they need to do something about the compilers as the compiled binaries get more bloated with each release.
The next south african company that this needs to be done to is DSTV. They are much worse than MTN. I always wonder if they are incompetent because they are south african or because Nigeria isn't serious about regulations. This question is binary.
Square probably has solid fundamentals but a mixture of factors has caused this problem in which they find themselves: bad performance of other tech IPOs so far this year and the nature of its CEO's job. The performance of other tech IPOs this year has left a bad taste in the mouths of the public markets. Jack Dorsey is also the CEO of Twitter and is not fully committing to either Square or Twitter. I think they'll do fine but unfortunately I'm not the market.
Square probably has solid fundamentals but a mixture of factors have caused this: bad performance of other tech IPOs so far this year and the nature of the CEOs job. I think they'll do fine but unfortunately I'm not the market.
I doubt that they'd be able to correct this with software. Take for example Mineral X. A concentration higher than 1mg/ml of X in blood may indicate disease D. Imagine that the tip of the finger has a much higher percentage of X than any other body parts. In testing for D you'd get a reading that may or may not be wrong as you wouldn't know if a high concentration of X is as a result of disease D or as a result of the machine's inherent error. Your screwed both ways. Theranos should understand that it isn't just a traditional software company that can release an MVP for the public. One screw up and their reputation is tarnished for ever. Just ask Volkswagen ;)
Getting blood from someone's finger will lead to incorrect results in many tests because other things diffuse into the blood. The things can lead to very inaccurate results. This is a BIG problem for Theranos.
I know that Github was bootstrapped and profitable before ever receiving VC funding. Given this how much control were the founders able to retain pertaining to voting rights, ownership percentages and board seats?
Another thing here is that these companies are getting valuations that imply that they will have very high margins in the future. But some of them will not be able to make good revenues without having MILLIONS of users. They will have to compete against themselves (eg. postmates, doordash et al). Simply put it's not remotely possible for most of these businesses to exist together and have such high valuations. These companies will make their respective markets as competitive as the airline industry (which has so many players but have such squeezed profits).
The companies are being valued like they'll be monopolies or duopolies someday, but the fact is that they are in businesses that have relatively low points of entry. My problem is not that X1 has a #1B valuation, my problem is that X1 has very similar competitors X2, X3, X4, ... Xn (where n is any number of competitors) that also have very high valuations in a market that cannot accommodate even a few of them. In some cases they have valuations that equal the total size of their addressable market. This is insane.